(Q28256350)
Statements
Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma (English)
0 references
1 September 2009
0 references
15
0 references
17
0 references
5445-56
0 references